12 Comments
As our nation looks to begin reopening, NIH continues to track how well our policies are meeting the evolving needs of the research community. In this post, we would like to highlight allowance of preliminary data as a new special exception to our post-submission materials policy and our guidance for reviewers.
Many of you are well aware that COVID-19 mitigation measures have adversely affected the ability of many researchers to generate preliminary data. Now that all 50 states have begun to reopen, and investigators may be better positioned to develop preliminary data, we want to give them the opportunity to have that data considered for this application submission round. The Guide Notice we issued today announces that for applications submitted for due dates beginning May 25, 2020 for the Fall 2020 review meetings/January 2021 Council round, NIH will accept a one-page update with preliminary data as post-submission materials for single component applications, or one page for each component of a multi-component application. A few items to note:
- The FOA must allow preliminary data.
- The deadline for submitting all post-submission materials, including preliminary data, will be 30 days before the study section meeting.
- Emergency competitive revisions and urgent competitive revisions, since they are undergoing expedited reviews, do not allow any type of post-submission materials.
As you are developing your application, you should keep in mind that NIH has issued guidance for reviewers. This guidance makes it clear that reviewers should assume that temporary, emergency situations resulting from the coronavirus pandemic will be rectified and/or dealt with by NIH staff, and therefore should not affect scores. It is the responsibility of NIH staff to request the information needed to resolve issues related to temporary, emergency conditions prior to award, as many of these temporary issues may be resolved before or during the early stages of the award.
We hope that the special exception for post-submission materials, and the guidance for reviewers, will provide our applicant community with some additional support as we all navigate this evolving landscape.
Note: the guidance for reviewers that is posted is for the summer 2020 meetings. We are developing reviewer guidance for the fall 2020 meetings.
Stringent Grants-Post-submission research protocols with timeline based flexibility for competitively reviewing the pilot research proposals/projects of scientifically mature, efficient, independent-thought process-bearing investigators with proven excellence in terms of senior authorships as evident in international peer-reviewed publications, should be developed and implemented to propel the ever-expanding medical research field at the NIH, USA-funded organizations with my diligent American contemporaries!
The expert grants management tem and scientific review panelists at the Maryland, Bethesda, USA-based American Grants Office NIH and associated divisions should encourage mutually respectful. ethical scientific conduct from scientists without perceived race/ethnicity/gender/marital-status related biases in the American grants/publications/research arenas.
Overall, I gained critical research insights from the expert NIH Grants management specialists!
I hope that the research will be successful and that we will get rid of COVID-19 faster
I hope that the research will be successful and that we will get rid of COVID-19 faster.
I hope that your research will help to find the vaccine for COVID-19.
I hope that the research will be successful so that we will get rid of the current situation.
I hope that your research will help to find the vaccine for COVID-19.
I hope that your research will help to find the vaccine for COVID-19
COVID-19 mitigation measures have adversely affected the ability of many researchers to generate preliminary data. It’s going to be 2020 after 2 months. I hope that your research will help to find the vaccine for COVID-19. Thank you.
Can anyone tell me about the recent updates about COVID-19 vaccines?
COVID-19 mitigation measures have adversely affected the ability of many researchers to generate preliminary data. It’s going to be 2020 after 2 months. I hope that your research will help to find the vaccine for COVID-19. Thank you.
I hope that the research will be successful.
COVID-19 mitigation measures have adversely affected the ability of many researchers to generate preliminary data. It’s going to be 2022 after 2 months